Nanolute Technology
NANOLUTE TECHNOLOGY is designed to improve the lipophilicity and bioavailability of Sirolimus
- Phospholipid is a drug carrier with two lipophilic tails and one hydrophilic head.
- Sirolimus is encapsulated in phospholipid with proprietary Nanolute technology.
Nanolute Technology
Conversion of Sirolimus drug into sub-micron sized particles
Nanocarriers created by encapsulation of sub-micron sized
Sirolimus drug into highly biocompatible drug
Carrier-phospholipid
Upon inflation of MagicTouch SCB at target site, nanocarriers
with Sirolimus drug inside gets transferred to the vessel wall
following the principle of co-efficient diffusion
Upon body pH variation, nanocarriers mimics the body lipids and
liberates Sirolimus
The sub-micron sized Sirolimus drug particles penetrate the
deepest layer of the vessel over a period
Unique Coating Technology
Drug carrier along with drug is coated on the unfolded balloon to achieve 100% coating on balloon surface
Unique and proprietary refolding mechanism facilitates better crossing profile
TECHNICAL SPECIFICATION
ORDERING INFORMATION
